Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Porcentajes variables de casos de lepra paucibacilar en la notificación global de casos de lepra.

Butlin CR, Lockwood DNJ. Revista de Leprología. 2020; 32 (6) : 441-449.
Publication

La influencia del poder colonial sobre la población y la naturaleza determinaron los asentamientos de la enfermedad de Hansen en Surinam.

Menke H, Pieters T, Menke J. Revista de Leprología. 2020; 32 (6) : 411-439.
Publication

Lepra borderline tuberculoide. Presentación de un caso.

González IB, Gutiérrez DF, Díaz Renón MT, et al. Revista de Leprología. 2020; 32 (6) : 395-400.
Publication

Lepra: a propósito de tres casos de presentación atípica.

Gutiérrez LF, Centurión I, Elli M, et al. Revista de Leprología. 2020; 32 (6) : 401-409.
Publication

Consejos sobre lepra y COVID-19.

ILEP . Revista de Leprología. 2020; 32 (6) : 451-453.
Publication

Why do Leprosy patients default treatment; Evidence from Sri Lanka

Arnold M. International Journal of Progressive Sciences and Technologies. 2020; 23 (2) : 654-659.
Download PDF
Publication

Perfil epidemiológico da hanseníase no município de anápolis – goiás entre os anos de 2015 a 2019

Sousa MVDP, Dutra ACF, De Lima GC, et al. Associacao Educativa Evangelica. Revista Educação em Saúde. 2020; 8 (2) : 57-63.
Download PDF
Publication

Hidroscopy as an Adjunctive Tool in the Assessment of Borderline Tuberculoid Hansen's Disease.

Kaur I, Jakhar D, Misri R. Indian dermatology online journal. 2020; 11 (6) : 1040-1041.
Download PDF
Publication

Functional biomarker signatures of circulating T-cells and its association with distinct clinical status of leprosy patients and their respective household contacts.

Marçal PHF, Gama R, de Oliveira L, et al. Infectious diseases of poverty. 2020; 9 (1) : 167.
Download PDF
Publication

The Dermlep Study Part 2: Results of a Nation-Wide Survey of Dermatologists' Access to Quality Leprosy Services at their Clinics and Hospitals in India.

Rao NP, Rathod S, Suneetha S, et al. Indian dermatology online journal. 2020; 11 (6) : 895-903.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 334
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD